• Crystal Violet Staining Solution: Precision in Fungal Pathog

  2026-04-22

  Explore the advanced utility of Crystal Violet Staining Solution as a nuclear staining dye, uniquely positioned to enhance precision in fungal virulence and antifungal resistance assays. This article bridges molecular epidemiology with protocol innovation for next-generation research.

• SlSLAH1-Orchestrated Malate Exudation Drives Aluminium Toler

  2026-04-22

  This study identifies the plasma membrane anion channel SlSLAH1 as a key regulator of aluminium (Al) tolerance in tomato via a SlSTOP1-activated malate exudation pathway. The findings illuminate the molecular mechanism linking transcriptional regulation and transporter function, with implications for breeding Al-tolerant crops and dissecting gene expression regulation under abiotic stress.

• Thapsigargin: SERCA Pump Inhibitor Workflows & Troubleshooti

  2026-04-21

  Thapsigargin, a gold-standard SERCA pump inhibitor, delivers precise and reproducible control over intracellular calcium—enabling advanced apoptosis, ER stress, and neurodegenerative disease research. This guide translates cutting-edge findings into actionable workflows, protocol enhancements, and troubleshooting strategies, ensuring robust data across diverse experimental models.

• Abiraterone Acetate: Advanced CYP17 Inhibition in 3D Models

  2026-04-21

  Leverage Abiraterone acetate’s potent CYP17 inhibition to dissect androgen biosynthesis in state-of-the-art 3D prostate cancer models. This guide delivers actionable workflows, protocol optimization, and troubleshooting strategies for researchers aiming to drive translational impact in castration-resistant and organ-confined prostate cancer studies.

• Toremifene in Breast Cancer: 20 Years of Data and Implicatio

  2026-04-20

  This review dissects two decades of clinical data on toremifene, a selective estrogen receptor modulator, and its impact on personalized breast cancer therapy. The findings underline the importance of molecular profiling and genetic testing in optimizing endocrine treatments and highlight the complementary utility of steroidal aromatase inhibitors such as exemestane in translational research.

• Patient-Derived 3D Spheroids: A Translational Model for Orga

  2026-04-20

  This study introduces a robust protocol for generating and characterizing patient-derived three-dimensional spheroid cultures from radical prostatectomy samples, enabling advanced in vitro modeling of organ-confined prostate cancer. The model demonstrates maintained viability, recapitulates tumor heterogeneity, and supports drug testing, offering significant translational utility for mechanistic and therapeutic research.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Benchmarking Precisi

  2026-04-19

  Discover how the Cy3 Goat Anti-Mouse IgG (H+L) Antibody empowers the most sensitive mouse IgG detection antibody protocols for early biomarker discovery. This article uniquely bridges advanced proteomics insights with workflow optimization for translational research.

• Amiloride (MK-870): Scenario Solutions for Sodium Channel Re

  2026-04-18

  This article delivers evidence-based, scenario-driven guidance for using Amiloride (MK-870) (SKU BA2768) in cell viability, ion transport, and endocytosis modulation assays. Biomedical researchers and lab technicians will find practical answers to real laboratory challenges, supported by literature and product data, highlighting how SKU BA2768 enables reproducible results and efficient workflows.

• Gepotidacin for Urogenital Gonorrhea: Phase 2 Efficacy Insig

  2026-04-17

  This article reviews a Phase 2 clinical study evaluating gepotidacin, a novel bacterial type II topoisomerase inhibitor, for the treatment of uncomplicated urogenital gonorrhea. The study demonstrates high efficacy of single oral doses against Neisseria gonorrhoeae, highlighting its potential as a future therapeutic option amid rising drug resistance.

• Lanabecestat (AZD3293): Applied Workflows in Alzheimer’s Res

  2026-04-16

  Harness the precision of Lanabecestat (AZD3293) for targeted amyloid-beta inhibition with proven synaptic safety. This guide delivers data-driven protocols, troubleshooting insights, and practical integration tips for Alzheimer’s disease research workflows.

• PPM-18: Optimizing iNOS Inhibition for Sepsis and Inflammati

  2026-04-15

  PPM-18 offers targeted, high-purity inhibition of iNOS via NF-κB pathway modulation, making it a vital tool for sepsis and inflammation research. This guide delivers practical workflows, troubleshooting strategies, and experimental insight to maximize reproducibility and translational value with PPM-18.

• Trichostatin A (TSA): HDAC Inhibitor for Epigenetic Assays

  2026-04-14

  Trichostatin A (TSA) is a potent histone deacetylase inhibitor used to interrogate epigenetic regulation, cell cycle arrest, and differentiation mechanisms in mammalian cell culture and animal models. It should be used where targeted, reversible HDAC inhibition is required, particularly in oncology and chromatin remodeling studies. TSA is not recommended for applications demanding aqueous solubility or extended solution stability.

• Human Peptide HLTP1 Attenuates Liver Transplant Injury via J

  2026-04-13

  A recent peer-reviewed study identified a novel human-derived peptide, HLTP1, which mitigates hepatic ischemia-reperfusion injury (HIRI) by inhibiting Jun N-terminal kinase (JNK) phosphorylation and hepatocyte apoptosis. This finding introduces a new translational avenue for improving liver transplantation outcomes and highlights advanced apoptosis detection methodologies.

• Safeguarding Phosphorylation: Precision Inhibitor Use in Pro

  2026-04-13

  Explore the mechanistic necessity and strategic deployment of EDTA-free Protease and Phosphatase Inhibitor Cocktails for preserving protein integrity and phosphorylation states. Drawing from recent mechanistic studies and scenario-driven lab insights, this article guides translational researchers in optimizing workflows for high-fidelity protein analysis, with a focus on APExBIO’s advanced formulation.

• VDR-Mediated Ferroptosis Drives Salivary Hyposecretion in So

  2026-04-12

  This study reveals that upregulation of the vitamin D receptor (VDR) promotes ferroptosis-related impairment of salivary secretion in female Sod1 knockout mice. By connecting oxidative stress, sex-specific VDR expression, and ferroptosis pathways, the research provides new mechanistic insights into xerostomia pathogenesis and highlights potential targets for therapeutic intervention.

16136 records 1/1076 page Next 12345 下5页 Last page